Indication Age special Length Frequence of Visits Administraion of IP Type
Lupus Female 18 – 75 Active skin rash Part A – 40 wks.  Part B – 28 wks Part A – 13 Visits, Part B – 9 Visits SC injection monoclonal antibody
Fibromyalgia Inclusive 18-80   18 Weeks 7 Visits Pill  
Insomnia Female (55+), Male (65+)   65days 9 visits, overnight stay (Day -6, Day 1-3, Day 29-31) Pill orexin receptor antagonist
Complex Regional Pain Syndrom 18 + Good dental hygiene 14 Months 11 Visits Intravenous neridronic acid
Uterine Fibroids Female 18+ Menstrual Cycles ≥ 21 days and ≤ 40 days 85 Weeks 13 Visits Pill GnRH-Antagonist
OA of the Knee or Hip 18 + Grade 2-3 KL 21 Months 15 Visits SC injection monoclonal antibody
OA of the Knee or Hip 18 + Grade 2-3 KL 41-45 wks 1/2wks x 2, 1/4wks x 4, 1/8wks, 1/16wks SC injection 2x monoclonal antibody
Gout 21-75 ≥ 1 tophus; Chronic gouty arthropathy; or 1 Gout Flare Up last 6 Months 217 Days 11 Visits Oral/Intravenous  
Major Depression Disorder 18 – 65 Monotherapy > 6 wks 19 wks 5 Visits Oral / Pill once daily serotonin modulator and stimulator
Cluster headaches Chronic 18 – 70 Caregiver 16 weeks 5 Visits SC injection monoclonal antibody
Cluster headaches Episodic 18 – 70 Caregiver 13 weeks 5 Visits SC injection monoclonal antibody
Migraines ≥ 18 years 2-14 Migraines per month (for last 3 months)     Oral calcitonin gene-related peptide (CGRP) receptor antagonist
Painful Diabetic Peripheral Neuropathy 18 – 75 A1C < 10 9 Months 11 visits Bilateral intramuscular injection (32 injections/4 visits) Hepatocyte growth factor